Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions View by Topic View by Date Must Reads In Dermatology Dermatology for January/February 2020 Psoriasis Elevates Cancer Risk, Acne Treatment May Vary Based on Race, Gender, Insurance, Registry Data Reveal Temporal Relationship Between Psoriasis Symptoms and PsA Onset, FDA Supports Sunscreen Safety Studies, Oral Lichen Planus Prevalence Estimates Go Global, More must reads Dermatology for November/December 2019 Adult Atopic Dermatitis Brings Increased Osteoporosis Risk, Atopic Dermatitis in Egg-, Milk-Allergic Kids May Up Anaphylaxis Risk, Certolizumab Safety Profile Varies Widely Across Indications, Naturopaths Emphasize Role of Diet in Atopic Dermatitis, Oral Baricitinib Performs Well in Phase 3 for Atopic Dermatitis, More must readsDermatology for September/October 2019 Short-Term Statin Use Linked to Risk of Skin and Soft Tissue Infections, Once-Daily Oral JAK Inhibitor for Atopic Dermatitis Effective in Phase 3 Study, Ixekizumab Surpasses Adalimumab in PsA Head-to-Head Study, Long-Term Opioid Use More Common in Hidradenitis Suppurativa, Severity, Itch Improvements Remain Steady With Ruxolitinib for Atopic Dermatitis, More must readsDermatology for July/August 2019 In Psoriasis, Risankizumab Outperforms Adalimumab, Topical Calcineurin Inhibitors Effective Treatment Option for Pediatric Periorificial Dermatitis, Racial, Ethnic Minorities Less Likely to Use Sun Protective Behaviors, Racial Disparities in Alopecia Areata Prevalence May Affect Diagnosis, Too many blood cultures ordered for pediatric SSTIs, More must readsDermatology for May/June 2019 Psoriasis Patients Often Have Positive Psoriatic Arthritis Screens, Intradermal Etanercept Improves Discoid Lupus, Hormone use impacts hair loss in transgender adults, Atopic dermatitis in adults associated with increased risk of dementia, More must readsPages« first 1 2 3 4 5 last »
